About HTLV-1
What Is HTLV-1?
Human T-cell Leukemia Virus Type 1 (HTLV-1) is a retrovirus that infects CD4+ T-lymphocytes, an important type of immune cell. It was the first human retrovirus discovered and affects millions of people worldwide.
Unlike viruses that cause immediate illness, HTLV-1 may remain silent in the body for decades. Most individuals never develop symptoms, but some may experience inflammatory, neurologic, or cancer-related complications later in life.
Currently, there is no definitive cure for HTLV-1 infection itself. However, many associated conditions can be treated, symptoms can often be managed, and research in antiviral therapy, immunotherapy, vaccines, and cellular therapies is rapidly evolving.
Sexual Contact
Breastfeeding
How Do People Get HTLV-1?
Blood transfusions
Shared needles/syringes
Organ transplantation
- HTLV-1 is NOT spread through:
How Do People Get HTLV-1?
Sexual Contact
Breastfeeding
Blood transfusions
Shared needles/syringes
Organ transplantation
- HTLV-1 is NOT spread through:
Who Is Affected?
- The Caribbean
- South America
- The Middle East
- Japan
- Parts of Africa
- Melanesia
Cases are also increasingly recognized in the United States and Europe, particularly in immigrant populations from endemic regions.
What Can HTLV-1 Lead To?
Most individuals
- Never develop symptoms
- Remain healthy carriers
However, a minority may develop
- Adult T-cell Leukemia/Lymphoma (ATLL)
- HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
- Skin disorders
- Eye inflammation (uveitis)
- Lung inflammation
- Other immune-related diseases
Why Haven't I Heard About It?
Many individuals with HTLV-1 are unaware they carry the virus. Early recognition may help:
- Reduce transmission
- Monitor for complications
- Identify complications earlier
- Improve access to specialized care
- Connect patients to clinical trials and support services
Education